SEELENBERGER ALEXANDER A. (Chief Financial Officer) purchased 53.1% of their position (10.50K shares) of VINCERX PHARMA, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/14/2023ACC: 0000950170-23-042406
Officer· Chief Financial Officer
Since Dec 2020
+10.50K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.50K
Price / share
$0.95
Trade value
$9.97K
% of position
53.1%
8/11/2023
19.78K→30.28K
Total
Net shares
+10.50K
Net value
$9.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2023 | P · Purchase | +10.50K | $0.95 | $9.97K | 53.1% | 19.78K | 30.28K |
| Total | +10.50K | $9.97K | ||||||
Derivative Transactions0
No derivative transactions reported